Yeh PY - Search Results

1

Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy.

Hsu CH, Hsu HC, Chen HL, Gao M, Yeh PY, Chen PJ, Cheng AL. Hsu CH, et al. Among authors: yeh py. Anticancer Res. 2004 Sep-Oct;24(5A):3035-40. Anticancer Res. 2004. PMID: 15517913 Free article.

2

Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin.

Yeh PY, Chuang SE, Yeh KH, Song YC, Cheng AL. Yeh PY, et al. Among authors: yeh kh. Biochem Biophys Res Commun. 2001 Jun 22;284(4):880-6. doi: 10.1006/bbrc.2001.5043. Biochem Biophys Res Commun. 2001. PMID: 11409876

3

Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation.

Yeh PY, Chuang SE, Yeh KH, Song YC, Ea CK, Cheng AL. Yeh PY, et al. Among authors: yeh kh. Biochem Pharmacol. 2002 Apr 15;63(8):1423-30. doi: 10.1016/s0006-2952(02)00908-5. Biochem Pharmacol. 2002. PMID: 11996883

4

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells.

Chuang SE, Yeh PY, Lu YS, Lai GM, Liao CM, Gao M, Cheng AL. Chuang SE, et al. Among authors: yeh py. Biochem Pharmacol. 2002 May 1;63(9):1709-16. doi: 10.1016/s0006-2952(02)00931-0. Biochem Pharmacol. 2002. PMID: 12007574

5

Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.

Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Wu TC, Gao M, Cheng AL. Hsu CH, et al. Among authors: yeh py. Anticancer Res. 2002 Nov-Dec;22(6C):4065-71. Anticancer Res. 2002. PMID: 12553034

6

Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells.

Yeh PY, Chuang SE, Yeh KH, Song YC, Cheng AL. Yeh PY, et al. Among authors: yeh kh. Biochem Pharmacol. 2003 Jul 1;66(1):25-33. doi: 10.1016/s0006-2952(03)00250-8. Biochem Pharmacol. 2003. PMID: 12818362

7

Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation.

Yeh PY, Yeh KH, Chuang SE, Song YC, Cheng AL. Yeh PY, et al. Among authors: yeh kh. J Biol Chem. 2004 Jun 18;279(25):26143-8. doi: 10.1074/jbc.M402362200. Epub 2004 Apr 8. J Biol Chem. 2004. PMID: 15073167 Free article.

8

Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death.

Yeh PY, Chuang SE, Yeh KH, Song YC, Chang LL, Cheng AL. Yeh PY, et al. Among authors: yeh kh. Oncogene. 2004 Apr 29;23(20):3580-8. doi: 10.1038/sj.onc.1207426. Oncogene. 2004. PMID: 15116093

9

Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.

Kuo SH, Chen LT, Yeh KH, Wu MS, Hsu HC, Yeh PY, Mao TL, Chen CL, Doong SL, Lin JT, Cheng AL. Kuo SH, et al. Among authors: yeh py, yeh kh. J Clin Oncol. 2004 Sep 1;22(17):3491-7. doi: 10.1200/JCO.2004.10.087. J Clin Oncol. 2004. PMID: 15337797

10

Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro.

Hsu CH, Gao M, Chen CL, Yeh PY, Cheng AL. Hsu CH, et al. Among authors: yeh py. Oncology. 2005;68(4-6):538-47. doi: 10.1159/000086998. Epub 2005 Jul 20. Oncology. 2005. PMID: 16037687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters